81 related articles for article (PubMed ID: 7583552)
1. Generation of pre-beta 1-HDL and conversion into alpha-HDL. Evidence for disturbed HDL conversion in Tangier disease.
Huang Y; von Eckardstein A; Wu S; Langer C; Assmann G
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1746-54. PubMed ID: 7583552
[TBL] [Abstract][Full Text] [Related]
2. Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency.
von Eckardstein A; Huang Y; Wu S; Funke H; Noseda G; Assmann G
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):691-703. PubMed ID: 7749883
[TBL] [Abstract][Full Text] [Related]
3. A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma.
Miccoli R; Zhu Y; Daum U; Wessling J; Huang Y; Navalesi R; Assmann G; von Eckardstein A
J Lipid Res; 1997 Jun; 38(6):1242-53. PubMed ID: 9215551
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL.
von Eckardstein A; Jauhiainen M; Huang Y; Metso J; Langer C; Pussinen P; Wu S; Ehnholm C; Assmann G
Biochim Biophys Acta; 1996 Jun; 1301(3):255-62. PubMed ID: 8664337
[TBL] [Abstract][Full Text] [Related]
5. Lipoproteins containing apolipoprotein A-IV but not apolipoprotein A-I take up and esterify cell-derived cholesterol in plasma.
von Eckardstein A; Huang Y; Wu S; Sarmadi AS; Schwarz S; Steinmetz A; Assmann G
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1755-63. PubMed ID: 7583553
[TBL] [Abstract][Full Text] [Related]
6. Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients.
von Eckardstein A; Huang Y; Kastelein JJ; Geisel J; Real JT; Kuivenhoven JA; Miccoli R; Noseda G; Assmann G
Atherosclerosis; 1998 May; 138(1):25-34. PubMed ID: 9678768
[TBL] [Abstract][Full Text] [Related]
7. High density lipoproteins and reverse cholesterol transport: lessons from mutations.
von Eckardstein A; Assmann G
Atherosclerosis; 1998 Apr; 137 Suppl():S7-11. PubMed ID: 9694535
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma.
Huang Y; von Eckardstein A; Wu S; Assmann G
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1412-8. PubMed ID: 7670956
[TBL] [Abstract][Full Text] [Related]
9. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
[TBL] [Abstract][Full Text] [Related]
10. Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I.
von Eckardstein A; Chirazi A; Schuler-Lüttmann S; Walter M; Kastelein JJ; Geisel J; Real JT; Miccoli R; Noseda G; Höbbel G; Assmann G
J Lipid Res; 1998 May; 39(5):987-98. PubMed ID: 9610765
[TBL] [Abstract][Full Text] [Related]
11. ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen MR
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1294-306. PubMed ID: 7670941
[TBL] [Abstract][Full Text] [Related]
12. Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles.
Asztalos B; Zhang W; Roheim PS; Wong L
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1630-6. PubMed ID: 9327755
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin: cholesterol acyltransferase.
Ohta T; Nakamura R; Ikeda Y; Shinohara M; Miyazaki A; Horiuchi S; Matsuda I
Biochim Biophys Acta; 1992 Nov; 1165(1):119-28. PubMed ID: 1420341
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol efflux from fibroblasts to discoidal lipoproteins with apolipoprotein A-I (LpA-I) increases with particle size but cholesterol transfer from LpA-I to lipoproteins decreases with size.
Agnani G; Marcel YL
Biochemistry; 1993 Mar; 32(10):2643-9. PubMed ID: 8448121
[TBL] [Abstract][Full Text] [Related]
15. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
[TBL] [Abstract][Full Text] [Related]
16. Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: its effect on the structure and cellular cholesterol-reducing capacity of LpA-I.
Ohta T; Ikeda Y; Hattori S; Matsuda I
Biochim Biophys Acta; 1996 Sep; 1303(2):137-44. PubMed ID: 8856043
[TBL] [Abstract][Full Text] [Related]
17. Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines.
Krimbou L; Hajj Hassan H; Blain S; Rashid S; Denis M; Marcil M; Genest J
J Lipid Res; 2005 Aug; 46(8):1668-77. PubMed ID: 15897603
[TBL] [Abstract][Full Text] [Related]
18. Phospholipids mediated conversion of HDLs generates specific apoA-II pre-beta mobility particles.
Wróblewska M; Kortas-Stempak B; Szutowicz A; Badzio T
J Lipid Res; 2009 Apr; 50(4):667-75. PubMed ID: 19066403
[TBL] [Abstract][Full Text] [Related]
19. Lipid binding properties of the Tangier apolipoprotein A-I and its isoproteins.
Rosseneu M; Assmann G; Taveirne MJ; Schmitz G
J Lipid Res; 1984 Feb; 25(2):111-20. PubMed ID: 6423754
[TBL] [Abstract][Full Text] [Related]
20. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins.
Frank PG; N'Guyen D; Franklin V; Neville T; Desforges M; Rassart E; Sparks DL; Marcel YL
Biochemistry; 1998 Sep; 37(39):13902-9. PubMed ID: 9753480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
